n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Kahler Disease in 2 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bortezomib is commonly used in treating multiple myeloma (MM)." | 7.79 | NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells. ( Chen, J; Li, S; Que, W, 2013) |
| "Bortezomib is commonly used in treating multiple myeloma (MM)." | 3.79 | NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells. ( Chen, J; Li, S; Que, W, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Que, W | 1 |
| Li, S | 1 |
| Chen, J | 1 |
| Zhang, M | 1 |
| Abe, Y | 1 |
| Matsushima, T | 1 |
| Nishimura, J | 1 |
| Nawata, H | 1 |
| Muta, K | 1 |
2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Kahler Disease
| Article | Year |
|---|---|
NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells.
Topics: Apoptosis; Boronic Acids; Bortezomib; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; | 2013 |
Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi | 2005 |